RSS   Newsletter   Contact   Advertise with us
Post Online Media

MyoKardia appoints June Lee as COO

MyoKardiaMyoKardia, a company focused on developing therapeutics to treat genetic heart disease, announced the appointment of June Lee as chief operating officer.
Article continues below

READ MORE MyoKardia appoints Marc Semigran as CMO

Dr. Lee comes to MyoKardia with significant early-stage development and portfolio experience.

Previously, Dr. Lee was on the faculty of the University of California, San Francisco (UCSF), where she was director of the Catalyst program at the Clinical and Translational Science Institute and a professor at the School of Medicine.

She worked in early clinical development in cardiovascular, metabolism, respiratory, and infectious diseases at Genentech.

Dr. Lee completed her undergraduate work in chemistry at the Johns Hopkins University and earned her M.D. degree at the School of Medicine at University of California, Davis.



We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy